Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul;36(1-3):101-7.
doi: 10.1023/A:1014060113186.

Molecular analysis of cross-reactive human monoclonal antibody AE6F4 generated by in vitro immunization: Epitope mapping of AE6F4 antibody on 14-3-3 family proteins and cytokeratin 8

A Ichikawa  1 , S Y Shim, Y Katakura, K Teruya, S Hashizume, S Shirahata
Affiliations

Molecular analysis of cross-reactive human monoclonal antibody AE6F4 generated by in vitro immunization: Epitope mapping of AE6F4 antibody on 14-3-3 family proteins and cytokeratin 8

A Ichikawa et al. Cytotechnology. 2001 Jul.

Abstract

We reported previously that adenocarcinoma-reactive human monoclonal antibody AE6F4, which had been generated by in vitro immunization method, recognizes both 14-3-3protein and cytokeratin 8 (CK8). In this study, to analyze the cross-reactivity of AE6F4 antibody, epitopes of AE6F4 antibody on 14-3-3 proteins and CK8 were studied by using synthetic linear peptide scanning technology. To determine the locations of B cell epitope, 48 and 95 of decapeptides covering the entire 14-3-3 proteins and CK8, respectively,were synthesized and binding to AE6F4 antibody was examined by ELISA. The AE6F4 antibody was strongly reactive to peptides containing amino acid sequences TLWTSDTQGD in 14-3-3 proteins and INFLRQLYEE in CK8. These results indicate that AE6F4 antibody can recognize the different peptide sequences in 14-3-3 proteins and CK8.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ichikawa A, Tachibana H, Kawamoto S, Kamei M, Honjoh T, Hashizume S, Shirahata S. Cytokeratin 8 and 19 as antigens recognized by adenocarcinoma-reactive human monoclonal antibody AE6F4. Hum Antibod. 1997;8:195–202. - PubMed
    1. Kawahara H, Shirahata S, Tachibana H, Murakami H. In vitro immunization of human peripheral blood lymphocytes with human cancer cell line A549. Hum Antibodies Hybridomas. 1992;3:8–13. - PubMed
    1. Kawamoto S, Shoji M, Setoguchi Y, Kato M, Hashizume S, Ichikawa A, Osada K, Katakura Y, Tachibana H, Murakami H. Molecular cloning of the 31 kDa cytosolic phospholipase A2, as an antigen recognized by the lung cancer specific human monoclonal antibody, AE6F4. Cytotechnology. 1995;17:103–108. doi: 10.1007/BF00749397. - DOI - PubMed
    1. Nakanishi K, Hashizume S, Kato M, Honjoh T, Setoguchi Y, Yasumoto K. Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. Hum Anitibod. 1997;8:189–194. - PubMed
    1. Shoji M, Kawamoto S, Sato S, Kamei M, Kato M, Hashizume S, Seki K, Yasumoto K, Nagashima A, Nakanishi H, Suzuki T, Imai T, Nomoto K, Murakami H. Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients. Hum Antibodies Hybridomas. 1994;5:116–122. - PubMed